-
Ophthotech Announces Strategic Review Plan
Post on 2/1/17
-
Synergy Pharmaceuticals Prices Public Offering of Common Stock
Post on 2/1/17
-
Pfizer (PFE) Q4 2016 Results - Earnings Call Transcript
Post on 2/1/17
-
Merck Makes Nice With Bristol-Myers Squibb
Post on 2/1/17
-
7 Things You Might Have Missed in Pfizer's Q4 Earnings Slip
Post on 2/1/17
-
Pfizer's 3 Fastest-Growing Drugs
Post on 2/1/17
-
It's Off! Aetna and Humana's Merger Is a Bust
Post on 2/1/17
-
UnitedHealthcare Partners with Camden Coalition
Post on 1/31/17
-
Blink Fitness Signs Multi-Unit Development Agreement
Post on 1/31/17
-
Synergy Pharmaceuticals Proposes Stock Offering
Post on 1/31/17
-
South Jersey Dental Study Club Expands its Continuing Education Programs to the Jersey Shore
Post on 1/31/17
-
Johnson & Johnson Acquisition Makes It Better
Post on 1/31/17
-
3 Biotech Stocks I'd Buy Right Now
Post on 1/31/17
-
Blink Fitness Opens Its Newest Bronx Location On Southern Boulevard
Post on 1/30/17
-
PhysicianOne Urgent Care Continues to Expand in Massachusetts With Newest Location in Medford
Post on 1/30/17
-
Johnson & Johnson (JNJ) Acquires Actelion (ALIOF)
Post on 1/30/17
-
Celgene To Acquire Delinia For Autoimmune Technology
Post on 1/30/17
-
Johnson & Johnson Sets Benchmark With Massive Actelion Price
Post on 1/30/17
-
Johnson & Johnson Too Rich For You? Try This High-Yielding Pharma Stock Instead
Post on 1/30/17
-
3 Most Unbelievably Undervalued Biotech Stocks
Post on 1/30/17
-
Better Buy: Pfizer Inc. vs. Johnson & Johnson
Post on 1/30/17
-
Better Buy: Johnson & Johnson vs. AbbVie
Post on 1/30/17
-
3 Reasons to Buy Pfizer Stock and Never Sell
Post on 1/30/17
-
Johnson & Johnson May Never Recoup Its Costs to Buy Actelion
Post on 1/30/17
-
The Valley Hospital Unveils Plan to Relocate and Build New Hospital
Post on 1/29/17
New York
